Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
METTL5 pseudogene 2 (METTL5P2) is a non-functional, likely non-coding pseudogene related to the METTL5 gene, which encodes an RNA methyltransferase that modifies 18S ribosomal RNA. Pseudogenes like METTL5P2 arise through gene duplication or retrotransposition events but typically lack the ability to produce an active protein product and are not considered therapeutic targets. In contrast, the active METTL5 enzyme has established roles in rRNA methylation and in the regulation of translational efficiency in cells, with emerging evidence of involvement in cancer cell biology and selenoprotein synthesis. Key clarification: - Any biological activity, disease association, or therapeutic targeting refers to the active METTL5 gene—not the METTL5P2 pseudogene. If your interest is in targeting methyltransferase activity for therapeutic reasons, the correct target would be the functional METTL5, not METTL5P2[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on METTL5 pseudogene 2 (METTL5P2).